Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: A randomized trial

Sewon Kang; Michael Goldfarb; Jonathan Weiss; Russell D. Metz; Ted Hamilton; John J. Voorhees; Christopher Em Griffiths

doi:10.1067/mjd.2003.451

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2001

Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.

Diane Thiboutot, Michael H. Gold, Michael Jarratt, Sewon Kang, David Kaplan, Larry E. Millikan, Jeremy D. Wolfe, Christian Loesche, Mark S. Baker

Article2006

Prevalence of Actinic Keratoses and Associated Factors in a Representative Sample of the Italian Adult Population

Luigi Naldi, Liliane Chatenoud, Roberto Piccitto, Paolo Colombo, Elena Benedetti Placchesi, Carlo La Vecchia

Article2015

Oral nicotinamide to reduce actinic cancer: A phase 3 double-blind randomized controlled trial.

Andrew Martin, Andrew Chen, Bonita Choy, Pablo Fernández‐Peñas, Gary M. Halliday, Robyn A. Dalziell, Catriona McKenzie, Richard A Scolyer, Haryana M. Dhillon, Janette L. Vardy, Gaya St George, Nira Chinniah, Diona L. Damian

Article2003

Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study

John E. Wolf, David Kaplan, Stephen J. Kraus, Keith H. Loven, Toivo Rist, Leonard J. Swinyer, Michael Baker, Yin S Liu, Janusz Czernielewski

Article2021

The impact of gender on researchers’ assessment: A randomized controlled trial

Marina Christ Franco, Lucas Helal, Maximiliano Sérgio Cenci, David Moher